申请人:AJINOMOTO CO. INC
公开号:US20020143023A1
公开(公告)日:2002-10-03
Dihydropyrimidine derivatives of the following formula or analogs thereof have selective N-type calcium channel antagonistic activity, and they are used as therapeutic agents for various diseases participating in the N-type calcium channels.
1
二氢嘧啶衍生物具有以下结构式或其类似物具有选择性N型钙通道拮抗活性,并且它们被用作参与N型钙通道的各种疾病的治疗药物。